135 related articles for article (PubMed ID: 36030167)
1. Targeting the GTV in medically inoperable endometrial cancer using brachytherapy.
Merfeld EC; Kuczmarska-Haas A; Burr AR; Witt JS; Francis DM; Ntambi JN; Desai VK; Huang JY; Miller JR; Lawless MJ; Wallace CR; Anderson BM; Bradley KA
Brachytherapy; 2022; 21(6):792-798. PubMed ID: 36030167
[TBL] [Abstract][Full Text] [Related]
2. Focal boost to residual gross tumor volume in brachytherapy for cervical cancer-A feasibility study.
Thiruthaneeswaran N; Groom N; Lowe G; Bryant L; Hoskin PJ
Brachytherapy; 2018; 17(1):181-186. PubMed ID: 29153466
[TBL] [Abstract][Full Text] [Related]
3. Image-based three-dimensional conformal brachytherapy for medically inoperable endometrial carcinoma.
Gill BS; Kim H; Houser C; Olsen A; Kelley J; Edwards RP; Comerci J; Sukumvanich P; Olawaiye AB; Huang M; Courtney-Brooks M; Beriwal S
Brachytherapy; 2014; 13(6):542-7. PubMed ID: 25127122
[TBL] [Abstract][Full Text] [Related]
4. Deformable image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical cancer brachytherapy planning.
Chapman CH; Polan D; Vineberg K; Jolly S; Maturen KE; Brock KK; Prisciandaro JI
Brachytherapy; 2018; 17(2):360-367. PubMed ID: 29331573
[TBL] [Abstract][Full Text] [Related]
5. Image-guided high-dose-rate intracavitary brachytherapy in the treatment of medically inoperable early-stage endometrioid type endometrial adenocarcinoma.
Jordan SE; Micaily I; Hernandez E; Ferriss JS; Miyamoto CT; Li S; Micaily B
Brachytherapy; 2017; 16(6):1144-1151. PubMed ID: 28958736
[TBL] [Abstract][Full Text] [Related]
6. Pilot study in the treatment of endometrial carcinoma with 3D image-based high-dose-rate brachytherapy using modified Heyman packing: clinical experience and dose-volume histogram analysis.
Weitmann HD; Pötter R; Waldhäusl C; Nechvile E; Kirisits C; Knocke TH
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):468-78. PubMed ID: 15890589
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of High Risk Clinical Target Volume reduction during Brachytherapy and impact on its coverage in patients with inoperable cervical cancer.
Pobijakova M; Scepanovic D; Paluga M; Fekete M; Mardiak J
Neoplasma; 2018 Mar; 65(3):425-430. PubMed ID: 29788726
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric comparison of stereotactic MR-guided radiation therapy (SMART) and HDR brachytherapy boost in cervical cancer.
Dincer N; Ugurluer G; Mustafayev TZ; Serkizyan A; Aydin G; Güngör G; Yapici B; Atalar B; Özyar E
Brachytherapy; 2024; 23(1):18-24. PubMed ID: 38000958
[TBL] [Abstract][Full Text] [Related]
9. A novel two-step optimization method for tandem and ovoid high-dose-rate brachytherapy treatment for locally advanced cervical cancer.
Sharma M; Fields EC; Todor DA
Brachytherapy; 2015; 14(5):613-8. PubMed ID: 26092424
[TBL] [Abstract][Full Text] [Related]
10. Dose volume analysis of radiotherapy for inoperable patients with stage I-II endometrial carcinoma.
Ohkubo Y; Kato S; Kiyohara H; Tsuruoka I; Tamaki T; Noda SE; Ohno T; Nakano T
J Radiat Res; 2011; 52(5):666-73. PubMed ID: 21857147
[TBL] [Abstract][Full Text] [Related]
11. Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched-pair analysis.
Schmid MP; Kirisits C; Nesvacil N; Dimopoulos JC; Berger D; Pötter R
Radiother Oncol; 2011 Sep; 100(3):468-72. PubMed ID: 21924510
[TBL] [Abstract][Full Text] [Related]
12. Dose escalation in brachytherapy for cervical cancer: impact on (or increased need for) MRI-guided plan optimisation.
Paton AM; Chalmers KE; Coomber H; Cameron AL
Br J Radiol; 2012 Dec; 85(1020):e1249-55. PubMed ID: 23175490
[TBL] [Abstract][Full Text] [Related]
13. Dose-volume histogram analysis of composite EQD2 dose distributions using the central shielding technique in cervical cancer radiotherapy.
Tamaki T; Noda SE; Ohno T; Kumazaki Y; Kato S; Nakano T
Brachytherapy; 2016; 15(5):598-606. PubMed ID: 27475482
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric feasibility of computed tomography-based image-guided brachytherapy in locally advanced cervical cancer: a Japanese prospective multi-institutional study.
Otani Y; Ohno T; Ando K; Murata K; Kato S; Noda SE; Murofushi K; Ushijima H; Yoshida D; Okonogi N; Isohashi F; Wakatsuki M; Nakano T
J Radiat Res; 2021 May; 62(3):502-510. PubMed ID: 33532828
[TBL] [Abstract][Full Text] [Related]
15. Intra-fractional dosimetric analysis of image-guided intracavitary brachytherapy of cervical cancer.
Yan J; Zhu J; Chen K; Yu L; Zhang F
Radiat Oncol; 2021 Aug; 16(1):144. PubMed ID: 34348758
[TBL] [Abstract][Full Text] [Related]
16. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional dose accumulation in pseudo-split-field IMRT and brachytherapy for locally advanced cervical cancer.
Sun B; Yang D; Esthappan J; Garcia-Ramirez J; Price S; Mutic S; Schwarz JK; Grigsby PW; Tanderup K
Brachytherapy; 2015; 14(4):481-9. PubMed ID: 25958039
[TBL] [Abstract][Full Text] [Related]
18. What is appropriate target delineation for MRI-based brachytherapy for medically inoperable endometrial cancer?
Carpenter DJ; Stephens SJ; Ayala-Peacock DN; Shenker RF; Raffi J; Meltsner SG; Craciunescu O; Chino JP
Brachytherapy; 2023; 22(2):181-187. PubMed ID: 36335036
[TBL] [Abstract][Full Text] [Related]
19. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
[TBL] [Abstract][Full Text] [Related]
20. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]